A Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Allergic Conjunctivitis

NCT04050865 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

96

Enrollment

INDUSTRY

Sponsor class

Conditions

Allergic Conjunctivitis

Interventions

DRUG: Dexamethasone, 0.4mg
DEVICE: Placebo plug with no drug

Sponsor

Ocular Therapeutix, Inc.